Document:

Exhibit
4.1

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD,
PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE
UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION
AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND,
IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.

 

Warrant
# 15

 

TRAQIQ,
INC.

Common
Stock Purchase Warrant

 

Issue
Date: February 17, 2021

Expiration
Date 3 Years from Issue Date

 

	For
    1,270,138 Shares	Price
    per Share: $0.001

 

THIS
CERTIFIES THAT, for value received, Lathika Ragunathan (the “Holder”) is entitled to purchase shares of the Common
Stock, $.0001 par value per share (the “Shares,” or, the “Warrant Stock”), of TraQiQ, Inc., a California
corporation (the “Company”), at $0.001 per share (such price, as it may be adjusted from time to time as specified
below, is referred to herein as the “Warrant Price”), subject to the provisions and upon the terms and conditions
hereinafter set forth. This Warrant is being issued in connection with that certain Exchange Agreement by and among the Company,
Holder and Mimo-Technologies Pvt. Ltd. (the “Exchange Agreement”).

 

1.
Term/Exercise; Vesting. 

 

1.1
Term/Exercise. Subject to the terms hereof, including in particular Section 1.2, the purchase right represented by this
Warrant is exercisable as to vested Warrant Stock, in whole or in part, at any time and from time to time, until the Expiration
Date noted above, provided that this Warrant will expire and be of no further force and effect upon the closing of (i) the sale
of all or substantially all of the assets of the Company, (ii) the sale of all of the issued and outstanding shares of the Company’s
capital stock, (iii) the effective date of a merger of the Company with another entity in which voting control of the Company
changes hands, or (iv) the sale of the Company’s capital stock in an initial public offering registered under the Act (any
one of which is a “Transaction”), if not exercised within ten (10) days of the Holder’s receiving the Company’s
written notice that a Transaction is pending.

 

1.2
Vesting. The Warrant shall vest into that number of Warrant Stock in accordance with the following vesting schedule (‘Vesting
Schedule”):

 

	Period	 	Warrant Stock Vesting
	As of the Issue Date	 	762,083
	As of January 31, 2022	 	Up to 317,5341
	As of January 31, 2023	 	Up to 190,5212

 

 

1
Up to 317,534 Shares, or such lesser amount thereof, may vest only in strict accordance with Section 1.1(b) of the Exchange
Agreement. 

2
Up to 190,521 Shares, or such lesser amount thereof, may vest only in strict accordance with Section 1.1(b) of the Exchange
Agreement. 

 

    	1

    	 

    

 

2.
Cash Exercise. The purchase right represented by this Warrant may be exercised by the Holder,
by the surrender of this Warrant (with the notice of exercise form attached hereto as Exhibit A duly executed) at the principal
office of the Company and by the payment to the Company, by cash, check or wire transfer, of an amount equal to the then applicable
Warrant Price per share multiplied by the number of Shares then being purchased.

 

3.
Stock Fully Paid; Reservation of Shares. All of the Shares that may be issued upon the exercise
of this Warrant will, upon issuance, in accordance with the provisions hereof, be fully paid and non-assessable, and free from
all taxes, liens and charges with respect to the issuance thereof. During the Term,
the Company will at all times have authorized and reserved for the purpose of issuance upon exercise of this Warrant, a sufficient
number of Shares to provide for the exercise of this Warrant

 

4.
Adjustment of Warrant Price and Number of Shares. The number and kind of securities purchasable
upon the exercise of this Warrant and the Warrant Price shall be subject to adjustment from time to time upon the occurrence of
certain events as follows:

 

4.1
Recapitalization or Conversion. In case of any recapitalization, reclassification, change or conversion of Warrant Stock
issuable upon exercise of this Warrant (other than a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of a subdivision or combination), this Warrant shall become exercisable for, in lieu of each share
of Warrant Stock theretofore issuable upon exercise of this Warrant, the kind and amount of shares of stock, other securities,
money and property receivable for a share of Warrant Stock upon such recapitalization, reclassification or conversion. Such new
Warrant shall provide for adjustments that shall be as nearly equivalent as may be practicable to the adjustments provided for
in this Section 4. Appropriate adjustments shall also be made to the Warrant Price, but the aggregate price payable pursuant to
this Warrant shall remain the same. The provisions of this Section 4.1 shall similarly apply to successive recapitalizations,
reclassifications and conversions.

 

4.2
Subdivision or Combination of Shares. If the Company at any time while this Warrant remains outstanding and unexpired shall
subdivide or combine its Warrant Stock, the number of shares of Warrant Stock issuable upon exercise hereof shall be proportionately
increased in the case of a subdivision and decreased in the case of a combination, and the Warrant Price shall be appropriately
adjusted such that the aggregate exercise price of this Warrant shall at all times remain the same.

 

4.3
Stock Dividends. If the Company at any time while this Warrant remains outstanding and unexpired shall pay a dividend payable
in, or make any other distribution of, shares of the Company’s stock (except any distribution specifically provided for
in Sections 4.1 and 4.2), then (i) the Warrant Price shall be adjusted, from and after the date of determination of stockholders
entitled to receive such dividend or distribution, to that price determined by multiplying the Warrant Price in effect immediately
prior to such date of determination by a fraction (x) the numerator of which shall be the total number of shares of the Company’s
capital stock outstanding immediately prior to such dividend or distribution, and (y) the denominator of which shall be the total
number of shares of the Company’s capital stock outstanding immediately after such dividend or distribution, and (ii) the
number of shares of Warrant Stock subject to this Warrant shall be proportionately adjusted.

 

    	2

    	 

    

 

4.4
No Impairment. The Company will not, by amendment of its Articles of Incorporation or through any reorganization, recapitalization,
transfer of assets, dissolution, issuance or sale of securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist
in the carrying out of all the provisions of this Section 4 and in the taking of all such action as may be necessary or appropriate
in order to protect the rights of the Holder, as the holder of this Warrant, against impairment.

 

5.
Notice of Adjustments. Whenever, while this Warrant remains outstanding and unexpired, the Warrant
Price shall be adjusted pursuant to the provisions hereof, the Company shall within 30 days of such adjustment deliver a certificate
signed by its chief financial officer to the Holder as the registered holder hereof setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Warrant Price
after giving effect to such adjustment.

 

6.
Fractional Shares. No fractional shares of Warrant Stock will be issued in connection with any
exercise hereunder, but in lieu of such fractional shares, the Company shall make a cash payment therefor upon the basis of the
Warrant Price.

 

7.
Transfers. This Warrant, together with all rights herein, are not transferable except with the
consent of the Company, which consent shall not be unreasonably withheld.

 

8.
Rights as Stockholder. The Holder, as the holder of the Warrant, shall not be entitled to vote
or receive dividends and shall not be deemed the holder of the Shares, nor shall anything contained herein be construed to confer
upon the Holder as the holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote for the
election of directors or upon any matter submitted to a vote of stockholders at any meeting thereof, or to receive notice of meetings,
until this Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable,
as provided herein.

 

9.
Modification and Waiver. This Warrant and any provision hereof may be changed, waived, discharged
or terminated only if expressly set forth in an instrument in writing signed by the Company and the Holder.

 

10.
Agreement to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant,
agrees to comply in all respects with the provisions of this Section 11 and the restrictive legend requirements set forth on the
face of this Warrant and further agrees that such Holder shall not offer, sell or otherwise dispose of this Warrant or any Warrant
Stock to be issued upon exercise hereof except under circumstances that will not result in a violation of the Securities Act of
1933, as amended (the “Securities Act”). This Warrant and all Warrant Stock issued upon exercise of this Warrant (unless
registered under the Securities Act) shall be stamped or imprinted with a legend in substantially the following form:

 

“THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD,
PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE
UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION
AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND,
IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”

 

    	3

    	 

    

 

11.
Representations of the Holder. In connection with the issuance of this Warrant, the Holder specifically
represents, as of the date hereof, to the Company by acceptance of this Warrant as follows:

 

11.1
The Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act. The Holder is acquiring this Warrant and the Warrant Stock to be issued upon exercise hereof for investment for its own account
and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant
Stock, except pursuant to sales registered or exempted under the Securities Act.

 

11.2
The Holder understands and acknowledges that this Warrant and the Warrant Stock to be issued upon exercise hereof are “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not
involving a public offering and that, under such laws and applicable regulations, such securities may be resold without registration
under the Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule
144 under the Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities
Act.

 

11.3
The Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period and has such
knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment
in the Warrant and the Warrant Stock. The Holder has had an opportunity to ask questions and receive answers from the Company
regarding the terms and conditions of the offering of the Warrant and the business, properties, prospects and financial condition
of the Company.

 

12.
Notices. All notices and other communications given or made pursuant hereto shall be in writing
and shall be deemed effectively given: (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed electronic
mail or facsimile if sent during normal business hours of the recipient; if not, then on the next business day, (iii) five (5)
days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) day after
deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All
communications shall be sent to the respective parties at the addresses on file with the Company (or at such other addresses as
shall be specified by notice given in accordance with this Section 10).

 

13.
Binding Effect on Successors. This Warrant shall be binding upon any corporation succeeding
the Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets, and all of the
covenants and agreements of the Company contained herein shall inure to the benefit of the successors and assigns of the holder
hereof. The Company will, at the time of the exercise of this Warrant, in whole or in part, upon request of the holder hereof
but at the Company’s expense, acknowledge in writing its continuing obligation to the holder hereof in respect of any rights
to which the holder hereof shall continue to be entitled after such exercise in accordance with this Warrant; provided, that the
failure of the holder hereof to make any such request shall not affect the continuing obligation of the Company to the holder
hereof in respect of such rights.

 

    	4

    	 

    

 

14.
Lost Warrants or Stock Certificates. The Company covenants to the holder hereof that upon receipt
of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant or any stock
certificate and in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the
Company, or in the case of any such mutilation upon surrender and cancellation of such Warrant or stock certificate, the Company
will make and deliver a new Warrant or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant
or stock certificate.

 

15.
Descriptive Headings. The descriptive headings of the several paragraphs of this Warrant are
inserted for convenience only and do not constitute a part of this Warrant.

 

16.
Governing Law. This Warrant shall be governed by, and construed under, the laws of the State
of Washington.

 

[signatures
on following page]

 

    	5

    	 

    

 

IN
WITNESS WHEREOF, the Company and Holder have caused this Warrant to be executed effective as of the date first written above.

 

	 	TraQiQ, Inc.
	 	 	 
	 	By:	
	 	 	Ajay
    Sikka, CEO
	 	 	 
	Acknowledged and Agreed to by the Holder as of February
    17, 2021.	 	 
	 	 	 
	 	 	 
	Lathika Regunathan	 	 

 

    	6

    	 

    

 

exhibit
a

 

Notice
of Exercise

 

	To:	TraQiQ,
    Inc. 
	 	 
	Attn:	CEO
	 	 
	Re:	Attached
    Warrant

 

The
undersigned hereby elects to purchase ____________ shares of Warrant Stock of TraQiQ, Inc. pursuant to the terms of Section 2
of this Warrant, and tenders herewith payment of the purchase price of such shares in full.

 

The
undersigned tenders the Warrant for exercise, and, if the stated number of shares is less than the total number of shares represented
by the Warrant, requests return of a replacement warrant representing the balance of shares.

 

Please
issue a certificate or certificates representing the resulting shares in the name of the undersigned or in such other name or
names as are specified below.

 

	 	Signature:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Address:	 
	 	 	 
	 	 	 
	 	 	 
	 	SSN
    or Tax ID:	 

 

    	 

     

    

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD,
PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE
UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION
AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND,
IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.

 

Warrant
# 16

 

TRAQIQ,
INC.

Common
Stock Purchase Warrant

 

Issue
Date: February 17 2021

Expiration
Date 3 Years from Issue Date

 

	For
    97,401 Shares	Price
    per Share: $0.001

 

THIS
CERTIFIES THAT, for value received, Suman  (the “Holder”) is entitled to purchase shares of the Common Stock,
$.0001 par value per share (the “Shares,” or, the “Warrant Stock”), of TraQiQ, Inc., a California corporation
(the “Company”), at $0.001 per share (such price, as it may be adjusted from time to time as specified below, is referred
to herein as the “Warrant Price”), subject to the provisions and upon the terms and conditions hereinafter set forth.
This Warrant is being issued in connection with that certain Exchange Agreement by and among the Company, Holder and Mimo-Technologies
Pvt. Ltd. (the “Exchange Agreement”).

 

1.
Term/Exercise; Vesting. 

 

1.1
Term/Exercise. Subject to the terms hereof, including in particular Section 1.2, the purchase right represented by this
Warrant is exercisable as to vested Warrant Stock, in whole or in part, at any time and from time to time, until the Expiration
Date noted above, provided that this Warrant will expire and be of no further force and effect upon the closing of (i) the sale
of all or substantially all of the assets of the Company, (ii) the sale of all of the issued and outstanding shares of the Company’s
capital stock, (iii) the effective date of a merger of the Company with another entity in which voting control of the Company
changes hands, or (iv) the sale of the Company’s capital stock in an initial public offering registered under the Act (any
one of which is a “Transaction”), if not exercised within ten (10) days of the Holder’s receiving the Company’s
written notice that a Transaction is pending.

 

1.2
Vesting. The Warrant shall vest into that number of Warrant Stock in accordance with the following vesting schedule (‘Vesting
Schedule”):

 

	Period	 	Warrant Stock Vesting
	As of the Issue Date	 	58,441
	As of January 31, 2022	 	Up to 24,3501
	As of January 31, 2023	 	Up to 14,6102

 

 

1
Up to 24,350 Shares, or such lesser amount thereof, may vest only in strict accordance with Section 1.1(b) of the Exchange
Agreement. 

2
Up to 14,610 Shares, or such lesser amount thereof, may vest only in strict accordance with Section 1.1(b) of the Exchange
Agreement. 

 

    	1

    	 

    

 

2.
Cash Exercise. The purchase right represented by this Warrant may be exercised by the Holder,
by the surrender of this Warrant (with the notice of exercise form attached hereto as Exhibit A duly executed) at the principal
office of the Company and by the payment to the Company, by cash, check or wire transfer, of an amount equal to the then applicable
Warrant Price per share multiplied by the number of Shares then being purchased.

 

3.
 Stock Fully Paid; Reservation of Shares. All of the Shares that may be issued upon the exercise
of this Warrant will, upon issuance, in accordance with the provisions hereof, be fully paid and non-assessable, and free from
all taxes, liens and charges with respect to the issuance thereof. During the Term, the Company will at all times have authorized
and reserved for the purpose of issuance upon exercise of this Warrant, a sufficient number of Shares to provide for the exercise
of this Warrant

 

4.
Adjustment of Warrant Price and Number of Shares. The number and kind of securities purchasable
upon the exercise of this Warrant and the Warrant Price shall be subject to adjustment from time to time upon the occurrence of
certain events as follows:

 

4.1
Recapitalization or Conversion. In case of any recapitalization, reclassification, change or conversion of Warrant Stock
issuable upon exercise of this Warrant (other than a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of a subdivision or combination), this Warrant shall become exercisable for, in lieu of each share
of Warrant Stock theretofore issuable upon exercise of this Warrant, the kind and amount of shares of stock, other securities,
money and property receivable for a share of Warrant Stock upon such recapitalization, reclassification or conversion. Such new
Warrant shall provide for adjustments that shall be as nearly equivalent as may be practicable to the adjustments provided for
in this Section 4. Appropriate adjustments shall also be made to the Warrant Price, but the aggregate price payable pursuant to
this Warrant shall remain the same. The provisions of this Section 4.1 shall similarly apply to successive recapitalizations,
reclassifications and conversions.

 

4.2
Subdivision or Combination of Shares. If the Company at any time while this Warrant remains outstanding and unexpired shall
subdivide or combine its Warrant Stock, the number of shares of Warrant Stock issuable upon exercise hereof shall be proportionately
increased in the case of a subdivision and decreased in the case of a combination, and the Warrant Price shall be appropriately
adjusted such that the aggregate exercise price of this Warrant shall at all times remain the same.

 

4.3
Stock Dividends. If the Company at any time while this Warrant remains outstanding and unexpired shall pay a dividend payable
in, or make any other distribution of, shares of the Company’s stock (except any distribution specifically provided for
in Sections 4.1 and 4.2), then (i) the Warrant Price shall be adjusted, from and after the date of determination of stockholders
entitled to receive such dividend or distribution, to that price determined by multiplying the Warrant Price in effect immediately
prior to such date of determination by a fraction (x) the numerator of which shall be the total number of shares of the Company’s
capital stock outstanding immediately prior to such dividend or distribution, and (y) the denominator of which shall be the total
number of shares of the Company’s capital stock outstanding immediately after such dividend or distribution, and (ii) the
number of shares of Warrant Stock subject to this Warrant shall be proportionately adjusted.

 

    	2

    	 

    

 

4.4
No Impairment. The Company will not, by amendment of its Articles of Incorporation or through any reorganization, recapitalization,
transfer of assets, dissolution, issuance or sale of securities or any other voluntary action, avoid or seek to avoid the observance
or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist
in the carrying out of all the provisions of this Section 4 and in the taking of all such action as may be necessary or appropriate
in order to protect the rights of the Holder, as the holder of this Warrant, against impairment.

 

5.
Notice of Adjustments. Whenever, while this Warrant remains outstanding and unexpired, the Warrant
Price shall be adjusted pursuant to the provisions hereof, the Company shall within 30 days of such adjustment deliver a certificate
signed by its chief financial officer to the Holder as the registered holder hereof setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Warrant Price
after giving effect to such adjustment.

 

6.
Fractional Shares. No fractional shares of Warrant Stock will be issued in connection with any
exercise hereunder, but in lieu of such fractional shares, the Company shall make a cash payment therefor upon the basis of the
Warrant Price.

 

7.
Transfers. This Warrant, together with all rights herein, are not transferable except with the
consent of the Company, which consent shall not be unreasonably withheld.

 

8.
Rights as Stockholder. The Holder, as the holder of the Warrant, shall not be entitled to vote
or receive dividends and shall not be deemed the holder of the Shares, nor shall anything contained herein be construed to confer
upon the Holder as the holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote for the
election of directors or upon any matter submitted to a vote of stockholders at any meeting thereof, or to receive notice of meetings,
until this Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable,
as provided herein.

 

9.
Modification and Waiver. This Warrant and any provision hereof may be changed, waived, discharged
or terminated only if expressly set forth in an instrument in writing signed by the Company and the Holder.

 

10.
Agreement to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant,
agrees to comply in all respects with the provisions of this Section 11 and the restrictive legend requirements set forth on the
face of this Warrant and further agrees that such Holder shall not offer, sell or otherwise dispose of this Warrant or any Warrant
Stock to be issued upon exercise hereof except under circumstances that will not result in a violation of the Securities Act of
1933, as amended (the “Securities Act”). This Warrant and all Warrant Stock issued upon exercise of this Warrant (unless
registered under the Securities Act) shall be stamped or imprinted with a legend in substantially the following form:

 

“THIS
WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD,
PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE
UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION
AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND,
IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.”

 

    	3

    	 

    

 

11.
Representations of the Holder. In connection with the issuance of this Warrant, the Holder specifically
represents, as of the date hereof, to the Company by acceptance of this Warrant as follows:

 

11.1
The Holder is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act. The Holder is acquiring this Warrant and the Warrant Stock to be issued upon exercise hereof for investment for its own account
and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant
Stock, except pursuant to sales registered or exempted under the Securities Act.

 

11.2
The Holder understands and acknowledges that this Warrant and the Warrant Stock to be issued upon exercise hereof are “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not
involving a public offering and that, under such laws and applicable regulations, such securities may be resold without registration
under the Securities Act only in certain limited circumstances. In addition, the Holder represents that it is familiar with Rule
144 under the Securities Act, as presently in effect, and understands the resale limitations imposed thereby and by the Securities
Act.

 

11.3
The Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period and has such
knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment
in the Warrant and the Warrant Stock. The Holder has had an opportunity to ask questions and receive answers from the Company
regarding the terms and conditions of the offering of the Warrant and the business, properties, prospects and financial condition
of the Company.

 

12.
Notices. All notices and other communications given or made pursuant hereto shall be in writing
and shall be deemed effectively given: (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed electronic
mail or facsimile if sent during normal business hours of the recipient; if not, then on the next business day, (iii) five (5)
days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) day after
deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All
communications shall be sent to the respective parties at the addresses on file with the Company (or at such other addresses as
shall be specified by notice given in accordance with this Section 10).

 

13.
Binding Effect on Successors. This Warrant shall be binding upon any corporation succeeding
the Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets, and all of the
covenants and agreements of the Company contained herein shall inure to the benefit of the successors and assigns of the holder
hereof. The Company will, at the time of the exercise of this Warrant, in whole or in part, upon request of the holder hereof
but at the Company’s expense, acknowledge in writing its continuing obligation to the holder hereof in respect of any rights
to which the holder hereof shall continue to be entitled after such exercise in accordance with this Warrant; provided, that the
failure of the holder hereof to make any such request shall not affect the continuing obligation of the Company to the holder
hereof in respect of such rights.

 

    	4

    	 

    

 

14.
Lost Warrants or Stock Certificates. The Company covenants to the holder hereof that upon receipt
of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant or any stock
certificate and in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the
Company, or in the case of any such mutilation upon surrender and cancellation of such Warrant or stock certificate, the Company
will make and deliver a new Warrant or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant
or stock certificate.

 

15.
Descriptive Headings. The descriptive headings of the several paragraphs of this Warrant are
inserted for convenience only and do not constitute a part of this Warrant.

 

16.
Governing Law. This Warrant shall be governed by, and construed under, the laws of the State
of Washington.

 

[signatures
on following page]

 

    	5

    	 

    

 

IN
WITNESS WHEREOF, the Company and Holder have caused this Warrant to be executed effective as of the date first written above.

 

	 	TraQiQ,
    Inc. 
	 	 
	 	By:	 
	 	 	Ajay
    Sikka, CEO

 

	Acknowledged
    and Agreed to by the Holder as of February 17, 2021.	 
	 	 
		 
	Suman 	 

 

    	6

    	 

    

 

exhibit
a

 

Notice
of Exercise

 

	To:	TraQiQ,
    Inc. 
	 	 
	Attn:	CEO
	 	 
	Re:	Attached
    Warrant

 

The
undersigned hereby elects to purchase ____________ shares of Warrant Stock of TraQiQ, Inc. pursuant to the terms of Section 2
of this Warrant, and tenders herewith payment of the purchase price of such shares in full.

 

The
undersigned tenders the Warrant for exercise, and, if the stated number of shares is less than the total number of shares represented
by the Warrant, requests return of a replacement warrant representing the balance of shares.

 

Please
issue a certificate or certificates representing the resulting shares in the name of the undersigned or in such other name or
names as are specified below.

 

	 	Signature:	 
	 	 	 
	 	Name:	 
	 	 	 
	 	Address:	 
	 	 	 
	 	 	 
	 	 	 
	 	SSN
    or Tax ID:Exhibit
10.1

 

EXCHANGE
AGREEMENT

 

This
EXCHANGE AGREEMENT (the “Agreement”), dated as of February 17, 2021 (the “Effective Date”)
between TraQiQ, Inc., a California corporation (“TraQiQ”), Mimo-Technologies Pvt. Ltd, an Indian corporation
(“Mimo”), the holders of all of the shares of Mimo executing this Agreement and listed on Exhibit A
hereto (each a “Mimo Shareholder” and collectively the “Mimo Shareholders”). Mimo and the
Mimo Shareholders shall be referred to as the Mimo Parties”.

 

WHEREAS,
the Mimo Shareholders collectively own all of the Mimo equity (the “Mimo Shares”) which consists of 14,943
shares of Mimo common stock; and

 

WHEREAS,
TraQiQ has common stock, par value $.0001 (“Common Stock”) registered with the Securities and Exchange Commission
pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “1934 Act”); and

 

WHEREAS,
subject to the terms and conditions of this Agreement, the Mimo Shareholders agree to exchange all of the Mimo Shares for warrants
to purchase shares of Common Stock at an exercise price of $.001 per share of Common Stock (the “TraQiQ Warrants”)
such that Mimo will become a wholly owned subsidiary of TraQiQ following the closing of (the “Share Exchange Transaction”).

 

NOW,
THEREFORE, in consideration of the premises and the mutual terms, conditions and other agreements set forth herein, intending
to be legally bound, the parties agree as follows:

 

Article
I

EXCHANGE

 

Section
1.1 Agreement to Exchange Mimo Shares for TraQiQ Warrants. On the Closing Date (as hereinafter defined) and upon the
terms and subject to the conditions set forth in this Agreement, Mimo Shareholders Lathika Regunathan and Suman shall each,
severally, sell, assign, transfer, convey and deliver to TraQiQ the Mimo Shares owned, severally, by Mimo Shareholders Lathika
Regunathan and Suman as specifically set forth opposite their name on Exhibit A hereto representing the total number
of the issued and outstanding equity of Mimo as set forth therein, and TraQiQ shall accept such securities from Mimo Shareholders
Lathika Regunathan and Suman in exchange for the issuance to Mimo Shareholders Lathika Regunathan and Suman of up
to 1,367,539 TraQiQ Warrants (the “Exchange Transaction”) as follows:

 

(a)
Issuance of Warrants at Closing. 820,524 TraQiQ Warrants in the form attached hereto as Exhibit B will be issued
and delivered to Mimo Shareholders at the Closing Date in the quantities set forth on Exhibit B.

 

    	 	1	 

    	 	 	 

    

 

(b)
Issuance of Warrants in Escrow. 547,015 TraQiQ Warrants (“Escrow Warrants”) shall be delivered
to TraQiQ to hold in escrow (“Escrow”) in the quantities set forth on Exhibit B. 341,884 Warrants shall
be delivered to the Mimo Shareholders if Mimo achieves gross revenue of U.S. $0.75 million (the “2021 Revenue goal”)
during the period of January 1, 2021-December 31, 2021 (the “2021 Target Period”) and 205,131 Warrants shall
be delivered to the Mimo Shareholders if Mimo achieves gross revenue of U.S. $01.25 million (the “2022 Revenue goal”)
during the period of January 1, 2022-December 31, 2022 (the “2022 Target Period”). In the event that Mimo does
not achieve the 2021 Revenue goal on the 2021 Target Period, or the 2022 Revenue goal in the 2022 Target Period, a proportional
amount of shares will be released. So, if Mimo reaches a revenue goal of $375,000 in 2021 half the warrants, 170,942, will be
released.

 

Section
1.2 Agreement to Exchange Mimo Shares for Cash. On the Closing Date, TraQiQ shall pay to Mimo Shareholder CIIE Initiatives
the sum of $ 22,337.60 determined by multiplying (i) 299 Mimo Shares owned by Mimo Shareholder CIIE Initiatives
by (ii) $74.7076 per Mimo Share (“Cash Transaction”).

 

Section
1.3 Closing. The closing of the Share Exchange Transaction and Cash Transaction (the “Closing”) shall
take place at 5:00 p.m. P.D.T. on the business day after which: (i) each of TraQiQ and the Mimo Shareholders has executed this
Agreement; and (ii) TraQiQ’s board of directors has approved a Form 8-K to be filed with SEC as required under the1934 Act;
(iii) TraQiQ’s board of directors has approved the Agreement, including without limitation issuance of the TraQiQ Warrants;
and (iv) all closing conditions have occurred, and (v) any necessary regulatory or governmental consents or waivers have been
obtained (hereinafter, the “Closing Date”).

 

Article
II

REPRESENTATIONS AND WARRANTIES OF TraQiQ

 

TraQiQ
hereby represents, warrants and agrees as follows:

 

Section
2.1 Corporate Organization.

 

(a)
TraQiQ is a corporation duly organized, validly existing and in good standing under the laws of California, and has all requisite
corporate power and authority to own its properties and assets and to conduct its business as now conducted and is duly qualified
to do business in good standing in each jurisdiction in which the nature of the business conducted by TraQiQ or the ownership
or leasing of its properties makes such qualification and being in good standing necessary, except where the failure to be so
qualified and in good standing will not have a material adverse effect on the business, operations, properties, assets, condition
or results of operation of TraQiQ (a “TraQiQ Material Adverse Effect”);

 

    	 	2	 

    	 	 	 

    

 

(b)
Copies of the Articles of Incorporation and Bylaws of TraQiQ are publicly available as exhibits to TraQiQs filings with the Securities
and Exchange Commission (“SEC”) and such copies are accurate and complete as of the date of this Agreement.

 

Section
2.2 Capitalization of TraQiQ.

 

(a)
The authorized and outstanding capital stock of TraQiQ as of the Effective Date consists of 300,000,000 shares of Common Stock,
par value $.0001 per share, of which 38,309,234 shares, options and warrants are issued and outstanding and 10,000,000 shares
of its Preferred Stock, par value $0.0001 per share, of which 50,000 shares of Series A preferred are currently issued and outstanding.
All issued and outstanding shares are duly authorized, validly issued and fully paid.

 

(b)
All of the TraQiQ Warrants to be issued on the Closing Date pursuant to this Agreement have been duly authorized and will be validly
issued. As of the Closing Date, there will be no outstanding options, warrants, agreements, commitments, conversion rights, preemptive
rights or other rights to subscribe for, purchase or otherwise acquire any shares of capital stock or any un-issued shares of
capital stock of TraQiQ other than as set forth on Schedule 2.2.a.

 

Section
2.3 Authorization and Validity of Agreements. TraQiQ has all corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery
of this Agreement by TraQiQ and the consummation by TraQiQ of the transactions contemplated hereby have been duly authorized by
all necessary corporate action of TraQiQ, and no other corporate proceedings on the part of TraQiQ are necessary to authorize
this Agreement or to consummate the transactions contemplated hereby.

 

    	3

     

    

 

Section
2.4 No Conflict or Violation. The execution, delivery and performance of this Agreement by TraQiQ does not and will
not violate or conflict with any provision of its Articles of Incorporation or Bylaws, as amended, and does not and will not violate
any provision of law, or any order, judgment or decree of any court or other governmental or regulatory authority, nor violate
or result in a breach of or constitute (with due notice or lapse of time or both) a default under, or give to any other entity
any right of termination, amendment, acceleration or cancellation of, any material contract, lease, loan agreement, mortgage,
security agreement, trust indenture or other agreement or instrument to which TraQiQ is a party or by which it is bound or to
which any of its properties or assets is subject, nor will it result in the creation or imposition of any material lien, charge
or encumbrance of any kind whatsoever upon any of the properties or assets of TraQiQ, nor will it result in the cancellation,
modification, revocation or suspension of any of material license, franchise, or permit to which TraQiQ is bound.

 

Section
2.5 Consents and Approvals. No consent, waiver, authorization or approval of any governmental or regulatory authority,
domestic or foreign, or of any other person, firm or corporation, is required in connection with the execution and delivery of
this Agreement by TraQiQ or the performance by TraQiQ of its obligations hereunder.

 

Section
2.6 Securities and Exchange Commission Reports. Since July 19, 2017, it has filed all material reports required by the
Securities and Exchange Act of 1934 (the “34 Act”).

 

Section
2.7 Litigation. No action, suit, or proceeding has been instituted or threatened before any court or other governmental
body or by any public authority to restrain, enjoin, or prohibit the Share Exchange Transaction or Cash Transaction, or which
would reasonably be expected to have a TraQiQ Material Adverse Effect. TraQiQ is not a party to any material legal proceeding.

 

Section
2.8 Subsidiaries. Except as set forth in its most recent Form 10-K and Form 10-Q, TraQiQ does not have any direct or
indirect subsidiaries and does not directly or indirectly own, control, or hold, with the power to vote, any shares of the capital
stock of any entity (including, without limitation, corporations, partnerships, and joint ventures). There are no outstanding
subscriptions, options, warrants, convertible securities, calls, commitments, or agreements calling for or requiring the issuance,
transfer, sale, or other disposition of any shares of the capital stock of TraQiQ except as set forth in Schedule 2.2a. Except
as already exists, there are no other direct or indirect subsidiaries of TraQiQ which would be or are required to be consolidated
or accounted for on the equity method in the consolidated financial statements of TraQiQ prepared in accordance with generally
accepted accounting principles.

 

    	4

     

    

 

Article
III

REPRESENTATIONS AND WARRANTIES OF MIMO PARTIES

 

On behalf of Mimo,
Lathika Regunathan represents and warrants to TraQiQ and agrees as follows:

 

Section
3.1 Organization.

 

(a)
Mimo is a corporation duly organized, validly existing and in good standing under the laws of the Country of India and has all
requisite corporate power and authority to own its properties and assets and to conduct its business as now conducted and is duly
qualified to do business in good standing in each jurisdiction where the nature of the business conducted by Mimo or the ownership
or leasing of their properties makes such qualification and being in good standing necessary, except where the failure to be so
qualified and in good standing will not have a material adverse effect on the business, operations, properties, assets, condition
or results of operation of Mimo (a “Mimo Adverse Effect”).

 

(b)
Copies of the governing documents of Mimo, with all amendments thereto to the date hereof, have been furnished to TraQiQ, and
such copies are accurate and complete as of the date hereof. The minute books of Mimo are current as required by law, contain
the minutes of all meetings of the Board of Directors and shareholders of Mimo, respectively, and committees of the Board of Directors
of Mimo from the date of incorporation to the date of this Agreement, and adequately reflect all material actions taken by the
Board of Directors, shareholders and committees of the Board of Directors of Mimo.

 

Section
3.2 Capitalization; Title. On the Closing Date, immediately before the transactions to be consummated pursuant to this
Agreement, Mimo shall have 14,943 Mimo Shares issued and outstanding and there will be no outstanding options, warrants, agreements,
commitments, conversion rights, preemptive rights or other rights to subscribe for, purchase or otherwise acquire any shares of
capital stock or any unissued or treasury shares of capital stock of Mimo. As of the date of this Agreement, the Mimo Shareholders
hold the Mimo Shares as set forth on Exhibit A, in each case, free and clear of any and all liens or encumbrances. Mimo
Shareholders each have the power and authority to sell, transfer, assign and delver each such Mimo Shareholders Mimo Shares, and
will convey to TraQiQ at the Closing Date good and valid title to such Mimo Shares Units free and clear of any and all liens and
encumbrances.

 

    	5

     

    

 

Section
3.3 Subsidiaries and Equity Investments; Assets. As of the Effective Date and on the Closing Date, Mimo does not and
will not directly or indirectly, own any shares of capital stock or any other equity interest in any entity nor any right to acquire
any shares or other equity interest in any entity.

 

Section
3.4 Authorization and Validity of Agreements. Each Mimo Party has all individual or corporate power and authority to
execute and deliver this Agreement, to perform their obligations hereunder and to consummate the transactions contemplated hereby.
The execution and delivery of this Agreement by Mimo and the consummation of the transactions contemplated hereby have been
duly authorized by all necessary corporate action and no other corporate proceedings on the part of Mimo are necessary to authorize
this Agreement or to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by each Mimo
Shareholder which is not a natural person (“Entity Holder”) and the consummation of the transactions contemplated
hereby by each Entity Holder have been duly authorized by all necessary action by the Entity Holder and no other proceedings on
the part of Mimo or any Mimo Holder are necessary to authorize this Agreement or to consummate the transactions contemplated hereby.

 

Section
3.5 No Conflict or Violation. (a) The execution, delivery and performance of this Agreement by the Mimo Parties does
not and will not violate or conflict with any provision of the constituent documents of Mimo or any Entity Holder, and does not
and will not violate any provision of law, or any order, judgment or decree of any court or other governmental or regulatory authority,
nor violate, result in a breach of or constitute (with due notice or lapse of time or both) a default under or give to any other
entity any right of termination, amendment, acceleration or cancellation of any contract, lease, loan agreement, mortgage, security
agreement, trust indenture or other agreement or instrument to which Mimo is bound or to which any of its respective properties
or assets is subject, nor result in the creation or imposition of any lien, charge or encumbrance of any kind whatsoever upon
any of the properties or assets of Mimo, nor result in the cancellation, modification, revocation or suspension of any of the
licenses, franchises, permits to which Mimo is bound, and (b) the execution, delivery and performance of this Agreement by any
Entity Holder does not and will not violate or conflict with any provision of the constituent documents of such Entity Holder,
and for all Mimo Shareholders does not and will not violate any provision of law, or any order, judgment or decree of any court
or other governmental or regulatory authority, nor violate, result in a breach of or constitute (with due notice or lapse of time
or both) a default under or give to any other entity any right of termination, amendment, acceleration or cancellation of any
contract, lease, loan agreement, mortgage, security agreement, trust indenture or other agreement or instrument to which such
Mimo Shareholder is bound.

 

    	6

     

    

 

Section
3.6 Financial Statements. The financial statements of Mimo for the years ended December 31, 2019 and 2020, consisting
of the unaudited balance sheets, statements of operations, statements of cash flows and statement of shareholders’ equity,
including all related notes, fairly present in all material respects the financial position of Mimo as at the respective dates
thereof.

 

Section
3.7 Investment Representations of each Mimo Shareholder.

 

(a)
The TraQiQ Warrants will be acquired hereunder by Lathika Regunathan and Suman solely for the account of such Mimo Shareholder,
for investment, and not with a view to the resale or distribution thereof, without prejudice, however, to Lathika Regunathan
and Suman’ right at all times to sell or otherwise dispose of all or any part of such Warrants under the Securities
Act of 1933, as amended (the “Securities Act”) and other applicable federal and state securities laws. Lathika
Regunathan and Suman understand and are able to bear any economic risks associated with their investment in
the TraQiQ Warrants. Lathika Regunathan and Suman have had full access to all the information they considers necessary
or appropriate to make an informed investment decision with respect to the TraQiQ Warrants to be acquired under this Agreement.
Lathika Regunathan and Suman further have had an opportunity to ask questions and receive answers from TraQiQ’s
management regarding TraQiQ and to obtain additional information (to the extent TraQiQ’s management possessed such information
or could acquire it without unreasonable effort or expense) necessary to verify any information furnished to Lathika Regunathan
and Suman or to which they had access.

 

(b)
Mimo Shareholder Status.

 

(i)
Each Mimo Shareholder hereby agrees and acknowledges that it is not a “U.S. Person” (as defined below) at the time
the Mimo Shareholder was offered the TraQiQ Warrants and as of the date hereof. For the purpose of this Agreement, a “U.S.
Person” means:

 

(A)
Any natural person resident in the United States;

 

(B)
Any partnership or corporation organized or incorporated under the laws of the United States;

 

    	7

     

    

 

(C)
Any estate of which any executor or administrator is a U.S. person;

 

(D)
Any trust of which any trustee is a U.S. person;

 

(E)
Any agency or branch of a foreign entity located in the United States;

 

(F)
Any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit
or account of a U.S. person;

 

(G)
Any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated,
or (if an individual) resident of the United States; or

 

(H)
Any partnership or corporation if (i) organized or incorporated under the laws of any foreign jurisdiction and (ii) formed by
a U.S. person principally for the purpose of investing in securities not registered under the 1933 Act, unless it is organized
or incorporated, and owned, by accredited investor(s) (as defined in Rule 501(a) of Regulation D promulgated under the 1933 Act)
who are not natural persons, estates or trusts.

 

“United
States” or “U.S.” means the United States of America, its territories and possessions, any State of the United
States, and the District of Columbia.

 

(ii)
Lathika Regunathan and Suman understand that no action has been or will be taken in any jurisdiction by TraQiQ that would
permit a public offering of the TraQiQ Warrants in any country or jurisdiction where action for that purpose is required.

 

(iii)
Lathika Regunathan and Suman as of the date of this Agreement and the Effective Date, (X) are located outside the
United States, and (Y) are not purchasing the TraQiQ Warrants for the account or benefit of any non-U.S. Person, except
in accordance with one or more available exemptions from the registration requirements of the 1933 Act or in a transaction not
subject thereto.

 

    	8

     

    

 

(iv)
Lathika Regunathan and Suman agrees not to resell the TraQiQ Warrants except in accordance with the provisions of Regulation
D, pursuant to a registration statement under the 1933 Act, or pursuant to an available exemption from registration; and agrees
not to engage in hedging transactions with regard to such securities unless in compliance with the 1933 Act.

 

(v)
Lathika Regunathan and Suman agrees, as applicable, to include statements in any documentation with regard to TraQiQ Warrants
to the effect that the securities have not been registered under the 1933 Act and may not be offered or sold in the United States
or to U.S. persons unless the securities are registered under the 1933 Act, or an exemption from the registration requirements
of the 1933 Act is available.

 

(vi)
No form of “directed selling efforts” (as defined under the 1933 Act), general solicitation or general advertising
in violation of the 1933 Act has been or will be used nor will any offers by means of any directed selling efforts in the United
States be made by Lathika Regunathan and Suman nor any of their representatives in connection with the offer and sale of
the TraQiQ Warrants.

 

(c)
To the best knowledge of Lathika Regunathan and Suman, this Agreement and the transactions contemplated herein are not
part of a plan or scheme to evade the registration provisions of the Securities Act, and the TraQiQ Warrants are being acquired
by each Mimo Shareholder for investment purposes.

 

(d)
Lathika Regunathan and Suman acknowledge and agree that the TraQiQ Warrants, upon issuance, shall bear the following
or similar legend:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE BEEN OFFERED IN AN TRANSACTION TO A PERSON WHO IS A U.S. PERSON (AS DEFINED HEREIN) PURSUANT
TO REGULATION D UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) OR A NON-U.S. PERSON (AS
DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE 1933 ACT. NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER
THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY,
IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS OR A NON-U.S. PERSON EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION
D OR S, RESPECTIVELY, UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY
IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED
UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED BY REGULATION
S UNDER THE 1933 ACT.”

 

    	9

     

    

 

Section
3.8 Brokers’ Fees. Neither Mimo nor any Mimo Shareholder has any liability to pay any fees or commissions or other
consideration to any broker, finder, or agent with respect to the transactions contemplated by this Agreement.

 

Section
3.9 Litigation. There is no action, suit, or proceeding which has been instituted or threatened before any court or
other governmental body or by any public authority to restrain, enjoin, or prohibit the Share Exchange Transaction or Cash Transaction,
or which would reasonably be expected to restrict materially the operation of the business of Mimo or the exercise of any rights
with respect thereto or to subject either TraQiQ or Mimo or any of their subsidiaries, directors, or officers to any liability,
fine, forfeiture, divestiture, or penalty on the ground that the transactions contemplated hereby, the parties hereto, or their
subsidiaries, directors, or officers have breached or will breach any applicable law or regulation or have otherwise acted improperly
in connection with the transactions contemplated hereby and with respect to which the parties hereto have been advised by counsel
that, in the opinion of such counsel, such action, suit, or proceeding raises substantial questions of law or fact which could
reasonably be decided materially adversely to either party hereto or its subsidiaries, directors, or officers.

 

Section
3.10 Employment Agreement. Lathika Regunathan, Mimo’s current Chief Executive Officer, will execute an employment
agreement, in the form customary for such position, which will provide that she will remain as Mimo CEO for a period of
two (2) years.

 

Article
IV

PRE-CLOSING COVENANTS

 

Section
4.1 Consents and Approvals. Without limitation of the foregoing, the parties shall:

 

(a)
use their reasonable commercial efforts to obtain all necessary consents, waivers, authorizations and approvals of all governmental
and regulatory authorities, domestic and foreign, and of all other persons, firms or corporations required in connection with
the execution, delivery and performance by them of this Agreement; and

 

    	10

     

    

 

(b)
diligently assist and cooperate with each party in preparing and filing all documents required to be submitted by a party to any
governmental or regulatory authority, domestic or foreign, in connection with such transactions and in obtaining any governmental
consents, waivers, authorizations or approvals which may be required to be obtained connection in with such transactions.

 

Section
4.2 Equity Issuance. From and after the Effective Date until the Closing Date, Mimo shall not issue any additional equity.
TraQiQ shall be entitled to sell Common Stock to investors prior to the Closing Date to provide working capital provided that
it provides notice to Mimo by means of an update to its disclosure of capitalization. The number of shares and share price in
any such sale of Common Stock will be determined by TraQiQ’s board of directors in its sole discretion.

 

Section
4.3 Subsequent Events. Five (5) days prior to the Closing Date, each party will advise the other party in a detailed
written notice of any fact or occurrence or any pending or threatened occurrence of which it obtains knowledge and which (if existing
and known at the Effective Date) would have been required to be set forth or disclosed in or pursuant to this Agreement or which
(if existing and known at any time prior to or at the Effective Date) would cause a condition either party’s obligations
under this Agreement not to be fully satisfied.

 

Section
4.4 Updated Schedules. Not less than five business days prior to the Closing Date, both parties will deliver to the
other party any updates to the schedules to its representations which may be required to disclose events or circumstances arising
after this date. Such schedules will be updated only for the purpose of making the representations and warranties contained in
this Agreement to which such part of such schedules relate true and correct in all material respects as of the date such schedule
is updated, and the updated schedule will not have the effect of making any representation or warranty contained in this Agreement
true and correct in all material respects as of a date prior to the date of such updated schedule. For purposes of determining
whether the conditions set forth in Article II for TraQiQ’s and Article III for Mimo’s obligations have
been met, any such updated schedules delivered to the other party will be disregarded unless TraQiQ OR Mimo will have agreed to
accept any changes reflected in such updated schedules.

 

    	11

     

    

 

Section
4.5 Rights of Access. Mimo will provide TraQiQ and to its representatives, including its certified public accountants,
full access during normal business hours to all of the property, documents, contracts, books, and records of Mimo, and such information
with respect to its business affairs and properties as TraQiQ from time to time may reasonably request.

 

Section
4.6 Extraordinary Transactions. Without the prior written consent of TraQiQ, Mimo will not, on or after the Effective
Date: (a) declare or pay any cash dividends or property dividends with respect to any class of its capital stock; (b) declare
or distribute any stock dividend, authorize a stock split, or authorize, issue or make any distribution of its capital stock or
any other securities or grant any options to acquire such additional securities; (c) either (i) merge into, consolidate with,
or sell or otherwise dispose of its assets to any other corporation or person, or enter into any other transaction or agree to
effect any other transaction not in the ordinary course of its business except as explicitly contemplated herein, or (ii) engage
in any discussions concerning such a possible transaction except as explicitly contemplated herein unless the board of directors
of Mimo, based upon the advice of legal counsel, determines in good faith that such action is required for the board of directors
to comply with its fiduciary duties to stockholders imposed by law; (d) convert the form of entity of Mimo from that in existence
on the Effective Date; (e) make any direct or indirect redemption, purchase, or other acquisition of any of its capital stock;
(f) except in the ordinary course of its business or to accomplish the transactions contemplated by this Agreement, incur any
liability or obligation, make any commitment or disbursement, acquire or dispose of any property or asset, make any contract or
agreement, pay or become obligated to pay any legal, accounting, or miscellaneous other expense, or engage in any transaction;
(g) other than in the ordinary course of business, subject any of its properties or assets to any lien, claim, charge, option,
or encumbrance; (h) enter into or assume any one or more commitments to make capital expenditures, any of which individually exceeds
$5,000 or which in the aggregate exceed $10,000; (i) except for increases in the ordinary course of business in accordance with
past practices, and except as explicitly contemplated by this Agreement, increase the rate of compensation of any employee or
enter into any agreement to increase the rate of compensation of any employee; (j) except as otherwise required by law, create
or modify any profit sharing plan, bonus, deferred compensation, death benefit, or retirement plan, or the level of benefits under
any such plan, nor increase or decrease any severance or termination pay benefit or any other fringe benefit; (k) enter into any
employment or personal services contract with any person or firm, except directly to facilitate the transactions contemplated
by this Agreement; nor (l) change the nature or increase the concentration of risk of investments and of cash and cash equivalents.

 

    	12

     

    

 

Section
4.7 Preservation of Business. Mimo will (a) carry on its business and manage its assets and properties diligently and
substantially in the same as heretofore; (b) use commercially reasonable efforts to continue in effect its present insurance coverage
on all properties, assets, business, and personnel; (c) use commercially reasonable efforts to preserve its business organization
intact, to keep available its present employees, and to preserve its present relationships with all those entities having business
dealings with it; (d) not do anything and not fail to do anything which will cause a breach of or default in any contract, agreement,
commitment, or obligation to which it is a party or by which it may be bound; and (e) conduct its affairs so that at the Closing
Date none of its representations and warranties will be inaccurate, none of its covenants and agreements will be breached, and
no condition in this Agreement will remain unfulfilled by reason of its actions or omissions.

 

Article
V

CONDITIONS TO OBLIGATIONS OF MIMO AND THE MIMO SHAREHOLDERS

 

The
obligations of Mimo and each Mimo Shareholder to consummate the transactions contemplated by this Agreement are subject to the
fulfillment, at or before the Closing Date, of the following conditions, any one or more of which may be waived by Mimo and by
Mimo Representative on behalf of each Mimo Shareholder in their sole discretion:

 

Section
5.1 Representations and Warranties of TraQiQ. All representations and warranties made by TraQiQ in this Agreement shall
be true and correct on and as of the Closing Date as if again made by TraQiQ as of such date.

 

Section
5.2 Agreements and Covenants. TraQiQ shall have performed and complied in all material respects to all agreements and
covenants required by this Agreement to be performed or complied with by it on or prior to the Closing Date.

 

Section
5.3 Consents and Approvals. Consents, waivers, authorizations and approvals of any governmental or regulatory authority,
domestic or foreign, and of any other person, firm or corporation, required in connection with the execution, delivery and performance
of this Agreement shall be in full force and effect on the Closing Date.

 

    	13

     

    

 

Section
5.4 No Violation of Orders. No preliminary or permanent injunction or other order issued by any court or governmental
or regulatory authority, domestic or foreign, nor any statute, rule, regulation, decree or executive order promulgated or enacted
by any government or governmental or regulatory authority, which declares this Agreement invalid in any respect or prevents the
consummation of the transactions contemplated hereby, or which materially and adversely affects the assets, properties, operations,
prospects, net income or financial condition of TraQiQ shall be in effect; and no action or proceeding before any court or governmental
or regulatory authority, domestic or foreign, shall have been instituted or threatened by any government or governmental or regulatory
authority, domestic or foreign, or by any other person, or entity which seeks to prevent or delay the consummation of the transactions
contemplated by this Agreement or which challenges the validity or enforceability of this Agreement, or subject a party hereto
or any of their directors, or officers to any liability, fine, forfeiture, divestiture, or penalty on the ground that the transactions
contemplated hereby, the parties hereto, or directors, or officers have breached or will breach any applicable law or regulation
or have otherwise acted improperly in connection with the transactions contemplated hereby and with respect to which the parties
hereto have been advised by counsel that, in the opinion of such counsel, such action, suit, or proceeding raises substantial
questions of law or fact which could reasonably be decided materially adversely to either party hereto or its subsidiaries, directors,
or officers.

 

Section
5.5 Other Closing Documents. Mimo shall have received such other certificates, instruments and documents in confirmation
of the representations and warranties of TraQiQ or in furtherance of the transactions contemplated by this Agreement as Mimo or
their counsel may reasonably request.

 

Article
VI

CONDITIONS TO OBLIGATIONS OF TRAQIQ

 

The
obligations of TraQiQ to consummate the transactions contemplated by this Agreement are subject to the fulfillment, at or before
the Closing Date, of the following conditions, any one or more of which may be waived by TraQiQ in its sole discretion:

 

Section
6.1 Representations and Warranties of Mimo Parties. All representations and warranties made by Mimo Parties in this
Agreement shall be true and correct on and as of the Closing Date as if again made by Mimo Parties on and as of such date.

 

Section
6.2 Agreements and Covenants. The Mimo Parties shall have performed and complied in all material respects to all agreements
and covenants required by this Agreement to be performed or complied with by it on or prior to the Closing Date.

 

    	14

     

    

 

Section
6.3 Consents and Approvals. All consents, waivers, authorizations and approvals of any governmental or regulatory authority,
domestic or foreign, and of any other person, firm or corporation, required in connection with the execution, delivery and performance
of this Agreement, shall have been duly obtained and shall be in full force and effect on the Closing Date.

 

Section
6.4 No Violation of Orders. No preliminary or permanent injunction or other order issued by any court or other governmental
or regulatory authority, domestic or foreign, nor any statute, rule, regulation, decree or executive order promulgated or enacted
by any government or governmental or regulatory authority, domestic or foreign, that declares this Agreement invalid or unenforceable
in any respect or which prevents the consummation of the transactions contemplated hereby, or which materially and adversely affects
the assets, properties, operations, prospects, net income or financial condition of Mimo, taken as a whole, shall be in effect;
and no action or proceeding before any court or government or regulatory authority, domestic or foreign, shall have been instituted
or threatened by any government or governmental or regulatory authority, domestic or foreign, or by any other person, or entity
which seeks to prevent or delay the consummation of the transactions contemplated by this Agreement or which challenges the validity
or enforceability of this Agreement.

 

Section
6.5 Other Closing Actions. TraQiQ shall have received such other certificates, instruments and documents in confirmation
of the representations and warranties of the Mimo Parties or in furtherance of the transactions contemplated by this Agreement
as TraQiQ or its counsel may reasonably request including, but not limited to, the Audit Report of its independent third party
auditor.

 

Article
VII

POST-CLOSING ACTIONS AND COVENANTS

 

Section
7.1 Delivery of Mimo Shares. Within five business days after the Closing Date, the Mimo Shareholders shall deliver original
certificates representing all of the Mimo Shares to TRAQIQ along with an executed assignment of such Mimo Shares.

 

Section
7.2 Issuance of TraQiQ Warrants. Within five business days of the Closing Date, TraQiQ shall issue the TraQiQ Warrants
as follows: (i) 820,524 TraQiQ Warrants shall be issued to the Mimo Shareholders as set forth in Exhibit B and (ii) 547,015
Escrow Warrants described in Section 1.1(b) hereto shall be delivered to TraQiQ in Escrow.

 

    	15

     

    

 

Article
VIII

TERMINATION AND ABANDONMENT

 

Section
8.1 Methods of Termination. This Agreement may be terminated, and the transactions contemplated hereby may be abandoned,
at any time before February 16, 2021. by notice of either TraQiQ or Mimo to the other party. No Mimo Shareholder shall have the
right to terminate the Agreement.

 

Article
IX

MISCELLANEOUS PROVISIONS

 

Section
9.1 Survival of Provisions. The respective representations, warranties, covenants and agreements of each of the parties
to this Agreement (except covenants and agreements which are expressly required to be performed and are performed in full on or
before the Closing Date) shall survive the Closing Date and the consummation of the transactions contemplated by this Agreement.
In the event of a breach of any of such representations, warranties or covenants, the party to whom such representations, warranties
or covenants have been made shall have all rights and remedies for such breach available to it under the provisions of this Agreement
or otherwise, whether at law or in equity, regardless of any disclosure to, or investigation made by or on behalf of such party
on or before the Closing Date.

 

Section
9.2 Publicity. No party shall cause the publication of any press release or other announcement with respect to this
Agreement or the transactions contemplated hereby without the consent of the other parties, unless a press release or announcement
is required by law. If any such announcement or other disclosure is required by law, the disclosing party agrees to give the non-disclosing
parties prior notice and an opportunity to comment on the proposed disclosure.

 

Section
9.3 Successors and Assigns. This Agreement shall inure to the benefit of, and be binding upon, the parties hereto and
their respective successors and assigns; provided, however, that no party shall assign or delegate any of the obligations created
under this Agreement without the prior written consent of the other parties.

 

Section
9.4 Fees and Expenses. Except as otherwise expressly provided in this Agreement, all legal and other fees, costs and
expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring
such fees, costs or expenses.

 

    	16

     

    

 

Section
9.5 Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed
to have been given or made if in writing and delivered personally or sent by registered or certified mail (postage prepaid, return
receipt requested) to the parties at the following addresses:

 

If
to Mimo or the Mimo Shareholders, to:

 

Mimo-Technologies
Pvt. Ltd

B-267A
Greater Kailash, Part I

New
Delhi 110048

Attention:
Lathika Regunathan

E-mail:
Lathika@mimo-technologies.com

 

If
to TraQiQ, to:

 

TraQiQ,
Inc.

14205
SE 36th Street, Suite 100

Bellevue,
WA 98006

Attention:
Ajay Sikka, CEO

E-mail:
ajay@TraQiQ.com

 

or
to such other persons or at such other addresses as shall be furnished by any party by like notice to the others, and such notice
or communication shall be deemed to have been given or made as of the date so delivered or mailed.

 

Section
9.6 Entire Agreement. This Agreement, together with the exhibits and schedules hereto, represents the entire agreement
and understanding of the parties with reference to the transactions set forth herein and no representations or warranties have
been made in connection with this Agreement other than those expressly set forth herein or in the exhibits, schedules, certificates
and other documents delivered in accordance herewith. This Agreement supersedes all prior negotiations, discussions, correspondence,
communications, understandings and agreements between the parties relating to the subject matter of this Agreement and all prior
drafts of this Agreement, all of which are merged into this Agreement. No prior drafts of this Agreement and no words or phrases
from any such prior drafts shall be admissible into evidence in any action or suit involving this Agreement.

 

Section
9.7 Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision
hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore,
in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part
of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible so as to be valid
and enforceable.

 

    	17

     

    

 

Section
9.8 Titles and Headings. The Article and Section headings contained in this Agreement are solely for convenience of
reference and shall not affect the meaning or interpretation of this Agreement or of any term or provision hereof.

 

Section
9.9 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original
and all of which together shall be considered one and the same agreement.

 

Section
9.10 Governing Law; Jurisdiction; Venue. This Agreement shall be governed by and interpreted and enforced in accordance
with the laws of the State of Washington without giving effect to the choice of law provisions thereof. The parties to this Agreement,
acting for themselves and for their respective successors and assigns, without regard to domicile, citizenship or residence, hereby
expressly and irrevocably elect as the sole judicial forum for the adjudication of any matters arising under or in connection
with this Agreement, and consent and subject themselves to the jurisdiction of, the courts of the State of Washington, County
of King, and/or the United States District in Seattle, Washington, in respect of any matter arising under this Agreement. Service
of process, notices and demands of such courts may be made upon any party to this Agreement by personal service at any place where
it may be found or giving notice to such party as provided in Section 9.5.

 

Section
9.11 Enforcement of the Agreement. The parties hereto agree that irreparable damage would occur if any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions hereto, this being in addition to any other remedy to which they are entitled at law or in equity.

 

Section
9.12 Amendments and Waivers. No amendment of any provision of this Agreement shall be valid unless the same shall be
in writing and signed by all of the parties hereto. No waiver by any party of any default, misrepresentation, or breach of warranty
or covenant hereunder, whether intentional or not, shall be deemed to extend to any prior or subsequent default, misrepresentation,
or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such
occurrence.

 

[Signature
Pages Follow]

 

    	18

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

	TRAQIQ,
    INC.	 
	 	 	 
	By:	 	 
	 	Ajay
    Sikka	 
	Its:	Chief
    Executive Officer	 

 

	Mimo-Technologies
    Pvt. Ltd	 
	 	 	 
	By:		 
	 	Lathika
    Regunathan	 
	Its:	Chief
    Executive Officer	 

 

[MIMO
Shareholder signatures on next page]

 

    	19

     

    

 

MIMO
SHAREHOLDERS

 

	Lathika
    Regunathan	 
	 	 	 
	By:	/s/	 
	 	Lathika
    Regunathan	 
	 	 	 
	Suman 	 
	 	 	 
	By:	/s/	 
	 	Suman 	 
	 	 	 
	CIIE
    Initiatives	 
	 	 	 
	By:	/s/	 
	 	Sanea
                                         Vakaliya

	 

 

    	20

     

    

 

Exhibit
A

 

MIMO
SHAREHOLDERS

 

	 	1	Lathika Regunathan	 	 	13,601	 	 	 	91.02	%
	 	2	Suman 	 	 	1,043	 	 	 	6.98	%
	 	3	CIIE Initiatives
	 	 	299	 	 	 	2.00	%
	 	 	 	 	 	14,943	 	 	 	100.00	%

 

    	21

     

    

 

EXHIBIT
B

 

WARRANT
DISTRIBUTION TO MIMO SHAREHOLDERS

 

	 	 	 	 	 	 	 	 	 	 	TraQiQ Warrant distribution	 
	 	 	Shareholder name	 	Mimo Shares	 	 	(%)	 	 	@Closing	 	 	@12 months	 	 	@24 months	 
	1	 	Lathika Regunathan	 	 	13,601	 	 	 	91.02	%	 	 	762,083	 	 	 	317,534	 	 	 	190,521	 
	2	 	Suman 	 	 	1,043	 	 	 	6.98	%	 	 	58,441	 	 	 	24,350	 	 	 	14,610	 
	 	 	 	 	 	14,644	 	 	 	100.00	%	 	 	820,524	 	 	 	341,884	 	 	 	205,131	 
	 	 	 	 	 	1,367,539	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

 

    	22

     

    

 

Schedule
2.2.a

Capitalization
of TraQiQ

List
of Outstanding Warrants, Options, or other Convertible Rights

 

 

 

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001514056

 

    	23

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]